Nancy Wainman

Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study

Eric Winquist, Jennifer J. Knox, Jean-Pierre M. Ayoub et al. · Investigational New Drugs · 2006 · 131 citations

Medicine, Oncology, Pharmacology +15

Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma

D. Scott Ernst, Elizabeth A. Eisenhauer, Nancy Wainman et al. · Investigational New Drugs · 2005 · 105 citations

Medicine, Oncology, Pharmacology +13

A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly

David J. Stewart, Ross C. Donehower, Elizabeth A. Eisenhauer et al. · Annals of Oncology · 2003 · 95 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +7

A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial

Christopher W. Lee, Karl Bélanger, Sanjay C. Rao et al. · Investigational New Drugs · 2007 · 93 citations

Medicine, Oncology, Pharmacology +14

Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks

Alison Davis, Karen A. Gelmon, Lillian L. Siu et al. · Investigational New Drugs · 2003 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +11